KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Total Current Liabilities (2016 - 2026)

Chemed filings provide 18 years of Total Current Liabilities readings, the most recent being $321.4 million for Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 10.62% year-over-year to $321.4 million, compared with a TTM value of $321.4 million through Mar 2026, up 10.62%, and an annual FY2025 reading of $287.1 million, up 0.5% over the prior year.
  • Total Current Liabilities hit $321.4 million in Q1 2026 for Chemed, up from $287.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $321.4 million in Q1 2026, with the low at $261.8 million in Q2 2024.
  • Median Total Current Liabilities over the past 5 years was $287.1 million (2025), compared with a mean of $288.5 million.
  • The sharpest move saw Total Current Liabilities decreased 13.47% in 2024, then grew 10.62% in 2026.
  • Year by year, Total Current Liabilities stood at $297.2 million in 2022, then rose by 4.99% to $312.0 million in 2023, then dropped by 8.45% to $285.7 million in 2024, then rose by 0.5% to $287.1 million in 2025, then increased by 11.94% to $321.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $321.4 million, $287.1 million, and $292.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.